EV Biologics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2017	FY 2017	FY 2016	FY 2015	FY 2014	2012 - 2013
Period Ending	Mar '25 Mar 19, 2025	Dec '17 Dec 31, 2017	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016	Jun '15 Jun 30, 2015	Jun '14 Jun 30, 2014	2012 - 2013
Market Capitalization	1	7	6	21	71	-	Upgrade
Market Cap Growth	-76.71%	6.82%	-70.36%	-71.13%	-	-	Upgrade
Enterprise Value	-	17	-14	0	68	-	Upgrade
Last Close Price	0.09	2.70	2.54	8.57	30.00	-	Upgrade
PE Ratio	-	-	-	-	8.21	-	Upgrade
PS Ratio	0.09	0.69	0.64	0.48	1.54	-	Upgrade
PB Ratio	0.02	0.15	1.64	1.83	1.53	-	Upgrade
P/TBV Ratio	0.02	0.16	3.69	2.26	1.71	-	Upgrade
P/FCF Ratio	-	-	-	-	17.02	-	Upgrade
P/OCF Ratio	-	-	3.93	1.55	11.49	-	Upgrade
EV/Sales Ratio	-	1.75	-	0.01	1.47	-	Upgrade
EV/EBITDA Ratio	-	-	-	0.09	4.66	-	Upgrade
EV/EBIT Ratio	-	106.82	-	0.16	5.29	-	Upgrade
EV/FCF Ratio	-	-	-	-	16.26	-	Upgrade
Debt / Equity Ratio	0.15	0.15	3.19	1.04	0.33	0.52	Upgrade
Debt / EBITDA Ratio	-	-	-	2.17	1.05	1.17	Upgrade
Debt / FCF Ratio	-	-	-	-	3.66	1.72	Upgrade
Asset Turnover	-	-	0.27	0.75	0.63	0.70	Upgrade
Inventory Turnover	-	-	26.51	71.77	74.69	74.71	Upgrade
Quick Ratio	0.80	0.80	0.23	0.34	0.84	1.83	Upgrade
Current Ratio	3.11	3.11	0.30	0.42	0.87	1.97	Upgrade
Return on Equity (ROE)	-	-	-99.17%	-183.68%	20.59%	33.15%	Upgrade
Return on Assets (ROA)	-	-	-7.05%	3.49%	10.92%	15.02%	Upgrade
Return on Capital (ROIC)	-	-	-12.74%	4.69%	13.50%	18.50%	Upgrade
Return on Capital Employed (ROCE)	0.40%	0.40%	-	28.20%	27.50%	27.20%	Upgrade
Earnings Yield	-6265.08%	-8.47%	-121.91%	-258.71%	12.19%	-	Upgrade
FCF Yield	-	-	-6.22%	-113.55%	5.88%	-	Upgrade
Buyback Yield / Dilution	-68.50%	-	-1.02%	-49.09%	-	-	Upgrade

Updated Nov 15, 2017. Source: S&P Global Market Intelligence. Standard template. Financial Sources.